Extract from the Register of European Patents

EP About this file: EP2964199

EP2964199 - DRY PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENT NANOPARTICLES BOUND TO CARRIER PARTICLES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.02.2021
Database last updated on 09.04.2026
FormerThe patent has been granted
Status updated on  20.03.2020
FormerGrant of patent is intended
Status updated on  29.10.2019
FormerExamination is in progress
Status updated on  16.12.2016
Most recent event   Tooltip14.01.2022Change - lapse in a contracting state
State(s) deleted from list of lapses: AL
published on 16.02.2022  [2022/07]
Applicant(s)For all designated states
Besins Healthcare Luxembourg SARL
2-8 rue Julien Vesque
2668 Luxembourg / LU
[2020/17]
Former [2016/02]For all designated states
Besins Healthcare Luxembourg SARL
2-8 rue Julien Vesque
2668 Luxembourg / LU
Inventor(s)01 / LICHTY, Maynard Emanuel
3604 Lochnora Parkway
Durham, North Carolina 27705 / US
02 / GWOZDZ, Garry T.
432 Pine Street
Jim Thorpe, Pennsylvania 18229 / US
 [2016/02]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2020/17]
Former [2016/02]Brown, David Leslie
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Application number, filing date14710757.703.03.2014
[2016/02]
WO2014US19833
Priority number, dateUS201361772095P04.03.2013         Original published format: US 201361772095 P
[2016/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014137877
Date:12.09.2014
Language:EN
[2014/37]
Type: A1 Application with search report 
No.:EP2964199
Date:13.01.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2014 takes the place of the publication of the European patent application.
[2016/02]
Type: B1 Patent specification 
No.:EP2964199
Date:22.04.2020
Language:EN
[2020/17]
Search report(s)International search report - published on:EP12.09.2014
ClassificationIPC:A61K9/16, A61K31/57, A61P15/18, A61K9/14
[2016/02]
CPC:
A61K9/1652 (EP,IL,US); A61K31/57 (EP,IL,RU,US); A61K31/573 (IL,RU);
A61K47/26 (IL,RU); A61K47/38 (IL,RU); A61K9/0034 (EP,IL,US);
A61K9/0043 (EP,IL,US); A61K9/14 (EP,IL,US); A61K9/16 (IL,RU);
A61K9/1682 (IL,US); A61P15/00 (EP,IL); A61P15/18 (EP,IL);
A61P25/00 (EP,IL); A61P9/00 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/02]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SPRÜHGETROCKNETE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT WIRKSTOFF-NANOTEILCHEN[2019/44]
English:DRY PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE AGENT NANOPARTICLES BOUND TO CARRIER PARTICLES[2016/02]
French:COMPOSITIONS PHARMACEUTIQUES SÉCHÉES PAR PULVÉRISATION CONTENANT DES NANOPARTICULES D'AGENT ACTIF[2019/44]
Former [2016/02]TROCKENE ARZNEIMITTELZUSAMMENSETZUNGEN MIT AN TRÄGERTEILCHEN GEBUNDENEN WIRKSTOFFNANOPARTIKELN
Former [2016/02]COMPOSITIONS PHARMACEUTIQUES SÈCHES COMPRENANT DES NANOPARTICULES D'AGENT ACTIF LIÉES À DES PARTICULES DE SUPPORT
Entry into regional phase14.09.2015National basic fee paid 
14.09.2015Designation fee(s) paid 
14.09.2015Examination fee paid 
Examination procedure14.09.2015Examination requested  [2016/02]
02.05.2016Amendment by applicant (claims and/or description)
07.06.2016Despatch of communication of loss of particular rights: Claims {1}
15.12.2016Despatch of a communication from the examining division (Time limit: M04)
18.04.2017Reply to a communication from the examining division
23.04.2018Despatch of a communication from the examining division (Time limit: M04)
26.06.2018Reply to a communication from the examining division
15.10.2019Cancellation of oral proceeding that was planned for 24.10.2019
24.10.2019Date of oral proceedings (cancelled)
30.10.2019Communication of intention to grant the patent
21.01.2020Fee for grant paid
21.01.2020Fee for publishing/printing paid
21.01.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.12.2016
Opposition(s)25.01.2021No opposition filed within time limit [2021/13]
Request for further processing for:Loss of rights: Claims
05.08.2016Request for further processing filed
05.08.2016Full payment received (date of receipt of payment)
Request granted
18.08.2016Decision despatched
Fees paidRenewal fee
29.02.2016Renewal fee patent year 03
27.03.2017Renewal fee patent year 04
15.03.2018Renewal fee patent year 05
27.03.2019Renewal fee patent year 06
13.03.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2022/07]
Former [2021/04]AL22.04.2020
Cited inInternational search[XI] WO2008075102  (PHARMAKODEX LTD et al.)
 [I] US2007031490  (LOEBENBERG RAIMAR et al.)
 [I] WO2007070851  (ACUSPHERE INC et al.)
 [A] WO2010131486  (SHIN NIPPON BIOMEDICAL LAB LTD et al.)
by applicantUS2010256091
 US5958458
 EP2116264
 US4807814
 US5785049
   SAYEED; STEIN ET AL.: "PROGRESS IN BRAIN RES", vol. 175, 2009, ELSEVIER B. V., pages: 219 - 37
   CHATURVEDI ET AL., J. ADV. PHARM. TECHNOL. RES., vol. 2, no. 4, 2011, pages 215 - 222
   KHAIRNAR ET AL., INT. J. PHARM. PHARM. SCI., vol. 3, 2011, pages 250
   MASTERS ET AL.: "THE SPRAY-DRYING HANDBOOK", 1991, LONGMAN SCIENTIFIC & TECHNICAL
   "Handbook of Pharmaceutical Excipients, Pharmaceutical Press", 2012, THE AMERICAN PHARMACEUTICAL ASSOCIATION AND THE ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN
   NEWMAN, S. P. ET AL.: "Aerosols and the Lung", 1984, BUTTERWORTH'S, pages: 197 - 224
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.